What is Pentavalent Vaccine

The pentavalent vaccine is a vaccine containing five live, inactivated organisms or purified antigens, formulated by a combination of producers for the prevention of multiple diseases or diseases caused by different species or serotypes of the same organism. The Pentavalent vaccine is definitely not a simple combination vaccine; each combination vaccine is a separate scientifically researched and independent vaccine.

The pentavalent vaccine is generally a combination vaccine against diphtheria, pertussis, tetanus, polio, and Haemophilus influenzae. The pentavalent vaccine not only reduces the total number of doses of vaccine that would otherwise be needed to prevent these five diseases from 12 to four, but also provides babies with the same level of immune protection as the individual vaccines.

Four doses of the Pentavalent vaccine for babies*** Three basic immunizations are given when babies are 2, 3, and 4 months old, and then a booster shot of the childhood Pentavalent vaccine is given when babies are 18 months old. If you miss your baby's 2-month-old vaccination, you can give your baby the basic immunization at 3, 4, and 5 months of age, and the booster immunization will still be given at 18 months of age.

Extended information

Vaccination precautions

1, should be used with caution for those suffering from thrombocytopenia coagulation disorder.

2. Pentavalent vaccine may contain small amounts of glutaraldehyde, neomycin, streptomycin, and polymyxin B, and should be used with caution in vaccinated individuals who are allergic to these substances.

3. Pentavalent vaccine should be considered with caution if there has been a history of non-febrile convulsions unrelated to the previous vaccination.

4. The benefits of tetanus toxoid-containing vaccination and its possible risks should be carefully considered if previous tetanus toxoid-containing vaccination has been followed by Guillain-Barre syndrome or brachial plexus neuritis. For infants who have not completed the basic immunization program (i.e., received <3 doses), continued vaccination can usually be considered.

5. If one is receiving immunosuppressive therapy or has an immunodeficiency disease; the body may reduce the immune response to the vaccine. Therefore, it is recommended to revaccinate after the treatment is completed.

Baidu Encyclopedia - Pentavalent Vaccine